
Job-ID: 61150
Location: Wien, AUT
Job Level: Professionals
Category: Technical
Employment Type: Permanent position
Become part of a vital chain and contribute to our common goal of making people's lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
As Group Lead Engineer - Fill & Finish, you will lead the engineering strategy for F&F, ensuring alignment with global production, technical standards, and business goals. You will provide technical guidance, mentor teams, drive standardization and innovation, and ensure compliance with safety, quality, and budget requirements.
The position will be located at one of our production sites: Stockholm, Lingolsheim, Springe, or Vienna.
Join us in shaping our vision to provide new health solutions advancing human life.
Austria Only:
The minimum gross wage according to the collective agreement (chemical industry) for your new job is EUR 4.270,14. We strive to adapt your salary to your range of tasks and to your profile, which is why we are ready to pay wages higher than collectively agreed. This is a legal requirement in Austria which is not applicable for other sites.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
If you have questions about the position, contact Johanna Hermansson (Responsible recruiter) at johanna.hermansson@octapharma.com. The application deadline Is 2026-03-31, but the position may be filled before then.
Visit our website Octapharma Career and follow us daily on LinkedIn.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.